Clinton Foundation, UNITAID Announces Reduction in Antiretroviral Rates

April 30, 2008 at 3:54 PM AIDS/HIV News
  •   Print
  •   Share
  •   Comments
  •  Text 
The Clinton Foundation HIV/AIDS Initiative and UNITAID announced that they have negotiated agreements with generic drug companies that will reduce the cost of some antiretroviral drugs and provide new pediatric formulations, the Wall Street Journal reports.

The agreements -- made with Indian drug makers Aurobindo Pharma, Cipla and Matrix Laboratories -- will provide discounts on more than 40 generic second-line antiretroviral drug formulations. They will reduce the price of the most commonly used second-line regimens -- tenofovir, lamivudine, and a combination of lopinavir and ritonavir -- according to the Journal.

The new prices are a reduction of as much as 19% when compared with the costs the organizations announced in May 2007, AFP/Yahoo! Newsreports. The new price for a second-line regimen containing tenofovir, lamivudine and lopinavir/ritonavir is a 16% reduction from the current average price in low-income countries and a 46% reduction in middle-income countries, AFP/Yahoo! News reports.

According to Clinton Foundation Chief Operating Officer Anil Soni, the agreements reduce the cost of second-line treatments for adults to about $659 annually from standard market costs of $1,000 to $4,000 annually in low- and middle-income countries, respectively.

UNITAID and CHAI also announced an agreement to provide a pediatric version of a zidovudine-based fixed dose combination therapy at a reduced price of $66 annually. UNITAID is providing a $120 million purchase commitment for 2008 to support the CHAI-negotiated discounts, Soni said.

In addition, UNITAID announced the addition of six new formulations to its pediatric HIV/AIDS treatment project that are more child-friendly than previous versions, according to a CHAI release. These new products include tablets, capsules and fixed-dose combinations that replace individual solutions, which often are difficult to dose, administer and store.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Vision Health Center

AIDS/HIV Related News

» Antibodies That Help to Stop HIV Virus Found in Breast Milk » Rectal Use of Reduced Glycerin Formulation of Tenofovir Vaginal Gel Deemed Safe
» Report Says Clergy can Fight HIV on Faith-Friendly Terms » HIV Epidemic may Afflict Nearly Half of Asia-Pacific Transgender People: UN
» 740,000 Lives Rescued With US AIDS Relief Program: Study » Include Behavioural Strategies in HIV Prevention Measures To Function: APA
» US Panel Urges Quick In-home HIV Test Approval » Funding Criminal Justice Reforms Key to Reducing Spread of HIV and TB in African Prisons
Read More >>